UX in Life Sciences: What’s Actually Different — and Why It Matters
In life sciences, the product isn’t the software — it’s the therapy. This opening UXLS article explores why that makes UX fundamentally different, and increasingly strategic.
In life sciences, the product isn’t the software — it’s the therapy. This opening UXLS article explores why that makes UX fundamentally different, and increasingly strategic.
Brought in late, forgotten after launch — that’s the project mindset. This UXLS article shows how a product mindset involves UX earlier, measures value continuously, and keeps it embedded.
Fragmented organizations leave UX potential untapped and practitioners isolated. This final UXLS article reveals what makes Communities of Practice thrive, what derails them, and how to start one.
The latest release of the industry’s shared digital language for medicinal product data adds structured packaging support, answering change requests raised by the group of experts who guide the ontology’s development.
This article explains how the IDMP Ontology bridges the gap between ISO IDMP standards and real-world implementation, enabling trusted, interoperable medicinal product data.
Clinical trial data is often difficult to find, integrate and reuse. This article introduces FAIR4Clin, the Pistoia Alliance’s practical guide to implementing FAIR principles across the clinical study lifecycle, helping organisations build data that is ready for regulatory use, cross-study analysis and AI.
Calling all Pistoia Alliance members — we’ve got a new book club idea, and we want your input before we get it off the ground.
IDMP-O gives regulators, manufacturers and healthcare providers a shared digital language for cross-border prescriptions, pharmacovigilance and medicine shortage monitoring
A major milestone for digital pharmaceutical manufacturing, version 1.0 delivers a standardized, machine-readable framework for CMC processes and is now available to Pistoia Alliance members.
Regulators keen for earlier engagement from pharma on AI, while poll reveals social media’s growing role in patient-centric drug development
The latest release strengthens regulatory compliance capabilities and deepens integration with the wider life sciences data ecosystem.
New Pistoia Alliance poll finds regulatory teams benefit most from AI, but just 1% see value in the wet lab.